Luke Sergott
Stock Analyst at Barclays
(4.71)
# 752
Out of 4,988 analysts
760
Total ratings
49%
Success rate
13.4%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Reiterated: Buy | $200 | $179.38 | +11.50% | 20 | Sep 18, 2026 | |
| LH Labcorp Holdings | Reiterated: Hold | $320 → $330 | $320.71 | +2.90% | 17 | Sep 11, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Hold | $22 | $19.93 | +10.39% | 22 | Sep 3, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $150 → $175 | $156.47 | +11.84% | 34 | Aug 27, 2026 | |
| BRKR Bruker | Reiterated: Buy | $58 | $61.39 | -5.52% | 20 | Aug 25, 2026 | |
| NTRA Natera | Reiterated: Buy | $260 → $340 | $369.39 | -7.96% | 15 | Aug 10, 2026 | |
| QGEN Qiagen | Reiterated: Hold | $38 → $40 | $43.33 | -7.69% | 18 | Aug 7, 2026 | |
| SHC Sotera Health Company | Reiterated: Buy | $19 → $22 | $18.73 | +17.46% | 43 | Aug 7, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | $40 → $52 | $76.60 | -32.11% | 35 | Aug 6, 2026 | |
| CERT Certara | Reiterated: Hold | $6.5 → $7.5 | $8.42 | -10.93% | 36 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 → $300 | $278.06 | +7.89% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.5 → $1.25 | $1.37 | -8.76% | 27 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $425 → $460 | $421.63 | +9.10% | 35 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $211.81 | +8.59% | 47 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $105 → $115 | $143.45 | -19.83% | 34 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,500 → $1,575 | $1,392.32 | +13.12% | 10 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $112 | $166.99 | -32.93% | 41 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $145 → $160 | $239.62 | -33.23% | 50 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 → $13 | $15.52 | -16.24% | 45 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 → $275 | $266.42 | +3.22% | 49 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $175 | $176.89 | -1.07% | 12 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 → $250 | $246.45 | +1.44% | 19 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $625 → $650 | $651.45 | -0.22% | 46 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $362.31 | +10.40% | 11 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $450 | $612.33 | -26.51% | 10 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 → $175 | $164.11 | +6.64% | 41 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 → $42 | $6.40 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 | $234.25 | n/a | 1 | Jan 18, 2023 |
Guardant Health
Sep 18, 2026
Reiterated: Buy
Price Target: $200
Current: $179.38
Upside: +11.50%
Labcorp Holdings
Sep 11, 2026
Reiterated: Hold
Price Target: $320 → $330
Current: $320.71
Upside: +2.90%
Fortrea Holdings
Sep 3, 2026
Reiterated: Hold
Price Target: $22
Current: $19.93
Upside: +10.39%
Agilent Technologies
Aug 27, 2026
Reiterated: Buy
Price Target: $150 → $175
Current: $156.47
Upside: +11.84%
Bruker
Aug 25, 2026
Reiterated: Buy
Price Target: $58
Current: $61.39
Upside: -5.52%
Natera
Aug 10, 2026
Reiterated: Buy
Price Target: $260 → $340
Current: $369.39
Upside: -7.96%
Qiagen
Aug 7, 2026
Reiterated: Hold
Price Target: $38 → $40
Current: $43.33
Upside: -7.69%
Sotera Health Company
Aug 7, 2026
Reiterated: Buy
Price Target: $19 → $22
Current: $18.73
Upside: +17.46%
10x Genomics
Aug 6, 2026
Reiterated: Buy
Price Target: $40 → $52
Current: $76.60
Upside: -32.11%
Certara
Aug 5, 2026
Reiterated: Hold
Price Target: $6.5 → $7.5
Current: $8.42
Upside: -10.93%
Aug 5, 2026
Reiterated: Buy
Price Target: $220 → $300
Current: $278.06
Upside: +7.89%
Aug 5, 2026
Reiterated: Sell
Price Target: $1.5 → $1.25
Current: $1.37
Upside: -8.76%
Aug 5, 2026
Reiterated: Buy
Price Target: $425 → $460
Current: $421.63
Upside: +9.10%
Aug 4, 2026
Reiterated: Buy
Price Target: $230
Current: $211.81
Upside: +8.59%
Aug 4, 2026
Reiterated: Hold
Price Target: $105 → $115
Current: $143.45
Upside: -19.83%
Aug 3, 2026
Reiterated: Buy
Price Target: $1,500 → $1,575
Current: $1,392.32
Upside: +13.12%
Aug 3, 2026
Reiterated: Buy
Price Target: $95 → $112
Current: $166.99
Upside: -32.93%
Jul 31, 2026
Reiterated: Sell
Price Target: $145 → $160
Current: $239.62
Upside: -33.23%
Jul 29, 2026
Reiterated: Sell
Price Target: $8 → $13
Current: $15.52
Upside: -16.24%
Jul 29, 2026
Reiterated: Buy
Price Target: $210 → $275
Current: $266.42
Upside: +3.22%
Jul 28, 2026
Reiterated: Buy
Price Target: $160 → $175
Current: $176.89
Upside: -1.07%
Jul 24, 2026
Reiterated: Buy
Price Target: $230 → $250
Current: $246.45
Upside: +1.44%
Jul 24, 2026
Reiterated: Buy
Price Target: $625 → $650
Current: $651.45
Upside: -0.22%
Jul 24, 2026
Reiterated: Buy
Price Target: $400
Current: $362.31
Upside: +10.40%
Jul 23, 2026
Reiterated: Hold
Price Target: $450
Current: $612.33
Upside: -26.51%
Jun 24, 2026
Reiterated: Hold
Price Target: $150 → $175
Current: $164.11
Upside: +6.64%
Jun 12, 2023
Reiterated: Hold
Price Target: $35 → $42
Current: $6.40
Upside: n/a
Jan 18, 2023
Rated: Buy
Price Target: $200
Current: $234.25
Upside: n/a